| Novel 8-(furan-2-yl)-3-substituted thiazolo [5, 4-e][1, 2, 4] triazolo [1, 5-c] pyrimidine-2 (3H)-thione derivatives as potential adenosine A2A receptor antagonists CB Mishra, SK Barodia, A Prakash, JBS Kumar, PM Luthra Bioorganic & medicinal chemistry 18 (7), 2491-2500, 2010 | 39 | 2010 |
| Neuron‐glia interactions: Molecular basis of alzheimer’s disease and applications of neuroproteomics AM Ibrahim, FH Pottoo, ES Dahiya, FA Khan, JBS Kumar European Journal of Neuroscience 52 (2), 2931-2943, 2020 | 33 | 2020 |
| In silico study of naphtha [1, 2-d] thiazol-2-amine with adenosine A2A receptor and its role in antagonism of haloperidol-induced motor impairments in mice PM Luthra, A Prakash, SK Barodia, R Kumari, CB Mishra, JBS Kumar Neuroscience letters 463 (3), 215-218, 2009 | 24 | 2009 |
| Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson’s disease R Kumari, JBS Kumar, PM Luthra Neuroscience Letters 589, 191-195, 2015 | 17 | 2015 |
| Plausible improvements for selective targeting of dopamine receptors in therapy of Parkinson's disease P Mehta Luthra, JB Senthil Kumar Mini Reviews in Medicinal Chemistry 12 (14), 1556-1564, 2012 | 12 | 2012 |
| Novel 8-(furan-2-yl)-3-benzyl thiazolo [5, 4-e][1, 2, 4] triazolo [1, 5-c] pyrimidine-2 (3H)-thione as selective adenosine A2A receptor antagonist SK Barodia, CB Mishra, A Prakash, JBS Kumar, N Kumari, PM Luthra Neuroscience letters 488 (1), 1-5, 2011 | 12 | 2011 |
| Modulation of indole ring annulation in ergoline template: chemistry, receptor binding and in vivo pharmacology with 6-OHDA model of Parkinson’s disease JB Senthil Kumar, R Kumari, PM Luthra Medicinal Chemistry Research 25, 596-608, 2016 | 6 | 2016 |
| One-pot synthesis of 3, 4-dihydropyridin-2-one via Michael addition of in situ–generated enaminones JB Senthil Kumar, N Kumari, PM Luthra Synthetic Communications 43 (22), 3010-3019, 2013 | 6 | 2013 |
